Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-07-04 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 99% confidence The document explicitly details 'Transactions in connection with share buy-back program' and provides a table showing the number of shares bought back and the average price paid over several days (June 27 to July 1, 2022). This activity directly corresponds to the company repurchasing its own shares. According to the definitions, this falls under 'Transaction in Own Shares (Code: POS)'. The document is a formal company announcement detailing the execution of a share repurchase program, not just a general regulatory filing (RNS) or a report publication announcement (RPA).
2022-07-04 English
Transactions in connection with share buy-back program
Regulatory Filings
2022-07-04 Danish
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program, including a table of daily share counts, average prices, and total values. This directly matches the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-07-04 Danish
6-K
Foreign Filer Report
2022-07-01 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document is titled "Major Shareholder Announcement" and explicitly states that Wellington Management Group LLP has informed Genmab A/S about a decrease in their holding of shares, resulting in a new percentage of 4.98% of the share capital and voting rights. This directly relates to changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a company announcement, the core content is the notification of a change in a major holding threshold.
2022-07-01 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled 'Major Shareholder Announcement' and details a change in shareholding percentage by Wellington Management Group LLP in Genmab A/S, citing the Danish Capital Markets Act. This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2022-07-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.